Axonal transport and mitochondrial dysfunction in alzheimer's disease

Neurodegenerative Diseases

Volumn 12, Issue 3, 2013, Pages 111-124

  Riemer, Jan ^a,b   Kins, Stefan ^b  

^a Divisions of Cellular Biochemistry ^*  (Germany)

^b Rheinland Pfälzische Technische Universität Kaiserslautern Landau   (Germany)

Author keywords

Amyloid precursor protein; Axonal transport; Mitochondria; Oxidative stress; Tau

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; MOLECULAR MOTOR; REACTIVE OXYGEN METABOLITE; TAU PROTEIN; RHO GUANINE NUCLEOTIDE BINDING PROTEIN;

ALZHEIMER DISEASE; BIOGENESIS; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENERGY YIELD; HUMAN; MITOCHONDRIAL RESPIRATION; NERVE DEGENERATION; NERVE ENDING; NERVE FIBER TRANSPORT; NEUROFIBRILLARY TANGLE; NEUROPATHY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN PHOSPHORYLATION; REVIEW; AMYLOID PLAQUE; MITOCHONDRIAL MEMBRANE; MITOCHONDRION; NERVE CELL CULTURE; NERVE FIBER DEGENERATION;

EID: 84884289093     PISSN: 16602854     EISSN: 16602862     Source Type: Journal    
DOI: 10.1159/000342020     Document Type: Review

References (177)

1. Selkoe DJ: Alzheimer's disease: genes, proteins, and therapy. Physiol Rev 2001; 81: 741-766.
2. Glenner GG, Wong CW: Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein. Biochem Biophys Res Commun 1984; 122: 1131-1135.
3. Masters CL, Simms G, Weinman NA, Multhaup G, McDonald BL, Beyreuther K: Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci USA 1985; 82: 4245-4249.
4. Aguzzi A, Haass C: Games played by rogue proteins in prion disorders and Alzheimer's disease. Science 2003; 302: 814-818.
5. Kang J, Lemaire HG, Unterbeck A, Salbaum JM, Masters CL, Grzeschik KH, Multhaup G, Beyreuther K, Muller-Hill B: The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 1987; 325: 733-736.
6. Goedert M, Wischik CM, Crowther RA, Walker JE, Klug A: Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease: identification as the microtubule-associated protein tau. Proc Natl Acad Sci USA 1988; 85: 4051-4055.
7. Wang Y, Garg S, Mandelkow EM, Mandelkow E: Proteolytic processing of tau. Biochem Soc Trans 2010; 38: 955-961.
8. Morishima M, Ihara Y: Posttranslational modifications of tau in paired helical filaments. Dementia 1994; 5: 282-288.
9. Gotz J, Gladbach A, Pennanen L, van Eersel J, Schild A, David D, Ittner LM: Animal models reveal role for tau phosphorylation in human disease. Biochim Biophys Acta 2010; 1802: 860-871.
10. Papasozomenos SC, Binder LI: Phosphorylation determines two distinct species of Tau in the central nervous system. Cell Motil Cytoskeleton 1987; 8: 210-226.
11. Dotti CG, Banker GA, Binder LI: The expression and distribution of the microtubule-associated proteins tau and microtubule-associated protein 2 in hippocampal neurons in the rat in situ and in cell culture. Neuroscience 1987; 23: 121-130.
12. Biernat J, Wu YZ, Timm T, Zheng-Fischhofer Q, Mandelkow E, Meijer L, Mandelkow EM: Protein kinase MARK/PAR-1 is required for neurite outgrowth and establishment of neuronal polarity. Mol Biol Cell 2002; 13: 4013-4028.
13. Spittaels K, Van den Haute C, Van Dorpe J, Geerts H, Mercken M, Bruynseels K, Lasrado R, Vandezande K, Laenen I, Boon T, Van Lint J, Vandenheede J, Moechars D, Loos R, Van Leuven F: Glycogen synthase kinase-3beta phosphorylates protein tau and rescues the axonopathy in the central nervous system of human four-repeat tau transgenic mice. J Biol Chem 2000; 275: 41340-41349.
14. Cho JH, Johnson GV: Primed phosphorylation of tau at Thr231 by glycogen synthase kinase 3beta (GSK3beta) plays a critical role in regulating tau's ability to bind and stabilize microtubules. J Neurochem 2004; 88: 349-358.
15. Ittner LM, Gotz J: Amyloid-beta and tau-a toxic pas de deux in Alzheimer's disease. Nat Rev Neurosci 2011; 12: 65-72.
16. Hutton M, Lendon CL, Rizzu P, Baker M, Froelich S, Houlden H, Pickering-Brown S, Chakraverty S, Isaacs A, Grover A, Hackett J, Adamson J, Lincoln S, Dickson D, Davies P, Petersen RC, Stevens M, de Graaff E, Wauters E, van Baren J, Hillebrand M, Joosse M, Kwon JM, Nowotny P, Heutink P, et al: Association of missense and 5 -splice-site mutations in tau with the inherited dementia FTDP-17. Nature 1998; 393: 702-705.
17. Poorkaj P, Bird TD, Wijsman E, Nemens E, Garruto RM, Anderson L, Andreadis A, Wiederholt WC, Raskind M, Schellenberg GD: Tau is a candidate gene for chromosome 17 frontotemporal dementia. Ann Neurol 1998; 43: 815-825.
18. Spillantini MG, Murrell JR, Goedert M, Farlow MR, Klug A, Ghetti B: Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. Proc Natl Acad Sci USA 1998; 95: 7737-7741.
19. Glabe CC: Amyloid accumulation and pathogensis of Alzheimer's disease: significance of monomeric, oligomeric and fibrillar Abeta. Subcell Biochem 2005; 38: 167-177.
20. Santacruz K, Lewis J, Spires T, Paulson J, Kotilinek L, Ingelsson M, Guimaraes A, DeTure M, Ramsden M, McGowan E, Forster C, Yue M, Orne J, Janus C, Mariash A, Kuskowski M, Hyman B, Hutton M, Ashe KH: Tau suppression in a neurodegenerative mouse model improves memory function. Science 2005; 309: 476-481.
21. Lewis J, Dickson DW, Lin WL, Chisholm L, Corral A, Jones G, Yen SH, Sahara N, Skipper L, Yager D, Eckman C, Hardy J, Hutton M, McGowan E: Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science 2001; 293: 1487-1491.
22. Selkoe DJ: Alzheimer's disease: a central role for amyloid. J Neuropathol Exp Neurol 1994; 53: 438-447.
23. Rapoport M, Dawson HN, Binder LI, Vitek MP, Ferreira A: Tau is essential to beta-amyloid- induced neurotoxicity. Proc Natl Acad Sci USA 2002; 99: 6364-6369.
24. Scheff SW, DeKosky ST, Price DA: Quantitative assessment of cortical synaptic density in Alzheimer's disease. Neurobiol Aging 1990; 11: 29-37.
25. DeKosky ST, Scheff SW: Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity. Ann Neurol 1990; 27: 457-464.
26. Heinonen O, Lehtovirta M, Soininen H, Helisalmi S, Mannermaa A, Sorvari H, Kosunen O, Paljarvi L, Ryynanen M, Riekkinen PJ Sr: Alzheimer pathology of patients carrying apolipoprotein E epsilon 4 allele. Neurobiol Aging 1995; 16: 505-513.
27. Scheff SW, Price DA, Schmitt FA, DeKosky ST, Mufson EJ: Synaptic alterations in CA1 in mild Alzheimer disease and mild cognitive impairment. Neurology 2007; 68: 1501-1508.
28. Morfini GA, Burns M, Binder LI, Kanaan NM, LaPointe N, Bosco DA, Brown RH Jr, Brown H, Tiwari A, Hayward L, Edgar J, Nave KA, Garberrn J, Atagi Y, Song Y, Pigino G, Brady ST: Axonal transport defects in neurodegenerative diseases. J Neurosci 2009; 29: 12776-12786.
29. Barkus RV, Klyachko O, Horiuchi D, Dickson BJ, Saxton WM: Identification of an axonal kinesin-3 motor for fast anterograde vesicle transport that facilitates retrograde transport of neuropeptides. Mol Biol Cell 2008; 19: 274-283.
30. Allen RD, Weiss DG, Hayden JH, Brown DT, Fujiwake H, Simpson M: Gliding movement of and bidirectional transport along single native microtubules from squid axoplasm: evidence for an active role of microtubules in cytoplasmic transport. J Cell Biol 1985; 100: 1736-1752.
31. Vale RD, Schnapp BJ, Mitchison T, Steuer E, Reese TS, Sheetz MP: Different axoplasmic proteins generate movement in opposite directions along microtubules in vitro. Cell 1985; 43: 623-632.
32. Nangaku M, Sato-Yoshitake R, Okada Y, Noda Y, Takemura R, Yamazaki H, Hirokawa N: KIF1B, a novel microtubule plus enddirected monomeric motor protein for transport of mitochondria. Cell 1994; 79: 1209-1220.
33. Trinczek B, Ebneth A, Mandelkow EM, Mandelkow E: Tau regulates the attachment/ detachment but not the speed of motors in microtubule-dependent transport of single vesicles and organelles. J Cell Sci 1999; 112 (Pt 14):2355-2367.
34. Hirokawa N, Takemura R: Molecular motors and mechanisms of directional transport in neurons. Nat Rev Neurosci 2005; 6: 201-214.
35. Pilling AD, Horiuchi D, Lively CM, Saxton WM: Kinesin-1 and Dynein are the primary motors for fast transport of mitochondria in Drosophila motor axons. Mol Biol Cell 2006; 7: 2057-2068.
36. Glater EE, Megeath LJ, Stowers RS, Schwarz TL: Axonal transport of mitochondria requires milton to recruit kinesin heavy chain and is light chain independent. J Cell Biol 2006; 173: 545-557.
37. Guo X, Macleod GT, Wellington A, Hu F, Panchumarthi S, Schoenfield M, Marin L, Charlton MP, Atwood HL, Zinsmaier KE: The GTPase dMiro is required for axonal transport of mitochondria to Drosophila synapses. Neuron 2005; 47: 379-393.
38. Lawrence CJ, Dawe RK, Christie KR, Cleveland DW, Dawson SC, Endow SA, Goldstein LS, Goodson HV, Hirokawa N, Howard J, Malmberg RL, McIntosh JR, Miki H, Mitchison TJ, Okada Y, Reddy AS, Saxton WM, Schliwa M, Scholey JM, Vale RD, Walczak CE, Wordeman L: A standardized kinesin nomenclature. J Cell Biol 2004; 167: 19-22.
39. Deboer SR, You Y, Szodorai A, Kaminska A, Pigino G, Nwabuisi E, Wang B, Estrada-Hernandez T, Kins S, Brady ST, Morfini G: Conventional kinesin holoenzymes are composed of heavy and light chain homodimers. Biochemistry 2008; 47: 4535-4543.
40. Tanaka Y, Kanai Y, Okada Y, Nonaka S, Takeda S, Harada A, Hirokawa N: Targeted disruption of mouse conventional kinesin heavy chain, kif5B, results in abnormal perinuclear clustering of mitochondria. Cell 1998; 93: 1147-1158.
41. Hurd DD, Saxton WM: Kinesin mutations cause motor neuron disease phenotypes by disrupting fast axonal transport in Drosophila. Genetics 1996; 144: 1075-1085.
42. Levy JR, Sumner CJ, Caviston JP, Tokito MK, Ranganathan S, Ligon LA, Wallace KE, LaMonte BH, Harmison GG, Puls I, Fischbeck KH, Holzbaur EL: A motor neuron disease- associated mutation in p150Glued perturbs dynactin function and induces protein aggregation. J Cell Biol 2006; 172: 733-745.
43. Varadi A, Johnson-Cadwell LI, Cirulli V, Yoon Y, Allan VJ, Rutter GA: Cytoplasmic dynein regulates the subcellular distribution of mitochondria by controlling the recruitment of the fission factor dynamin-related protein-1. J Cell Sci 2004; 117: 4389-4400.
44. Su Q, Cai Q, Gerwin C, Smith CL, Sheng ZH: Syntabulin is a microtubule-associated protein implicated in syntaxin transport in neurons. Nat Cell Biol 2004; 6: 941-953.
45. Cai Q, Gerwin C, Sheng ZH: Syntabulin-mediated anterograde transport of mitochondria along neuronal processes. J Cell Biol 2005; 170: 959-969.
46. Stowers RS, Megeath LJ, Gorska-Andrzejak J, Meinertzhagen IA, Schwarz TL: Axonal transport of mitochondria to synapses depends on milton, a novel Drosophila protein. Neuron 2002; 36: 1063-1077.
47. Fransson S, Ruusala A, Aspenstrom P: The atypical Rho GTPases Miro-1 and Miro-2 have essential roles in mitochondrial trafficking. Biochem Biophys Res Commun 2006; 344: 500-510.
48. Wozniak MJ, Melzer M, Dorner C, Haring HU, Lammers R: The novel protein KBP regulates mitochondria localization by interaction with a kinesin-like protein. BMC Cell Biol 2005; 6: 35.
49. Morris RL, Hollenbeck PJ: Axonal transport of mitochondria along microtubules and Factin in living vertebrate neurons. J Cell Biol 1995; 131: 1315-1326.
50. Langford GM: Myosin-V, a versatile motor for short-range vesicle transport. Traffic 2002; 3: 859-865.
51. Ruthel G, Hollenbeck PJ: Response of mitochondrial traffic to axon determination and differential branch growth. J Neurosci 2003; 23: 8618-8624.
52. Yi M, Weaver D, Hajnoczky G: Control of mitochondrial motility and distribution by the calcium signal: a homeostatic circuit. J Cell Biol 2004; 167: 661-672.
53. Saotome M, Safiulina D, Szabadkai G, Das S, Fransson A, Aspenstrom P, Rizzuto R, Hajnoczky G: Bidirectional Ca 2+ -dependent control of mitochondrial dynamics by the Miro GTPase. Proc Natl Acad Sci USA 2008; 105: 20728-20733.
54. Wang X, Schwarz TL: The mechanism of Ca 2+ -dependent regulation of kinesin-mediated mitochondrial motility. Cell 2009; 136: 163-174.
55. Macaskill AF, Rinholm JE, Twelvetrees AE, Arancibia-Carcamo IL, Muir J, Fransson A, Aspenstrom P, Attwell D, Kittler JT: Miro1 is a calcium sensor for glutamate receptor-dependent localization of mitochondria at synapses. Neuron 2009; 61: 541-555.
56. Horiuchi D, Barkus RV, Pilling AD, Gassman A, Saxton WM: APLIP1, a kinesin binding JIP-1/JNK scaffold protein, influences the axonal transport of both vesicles and mitochondria in Drosophila. Curr Biol 2005; 15: 2137-2141.
57. Horiuchi D, Collins CA, Bhat P, Barkus RV, Diantonio A, Saxton WM: Control of a kinesin- cargo linkage mechanism by JNK pathway kinases. Curr Biol 2007; 17: 1313-1317.
58. Miller KE, Sheetz MP: Axonal mitochondrial transport and potential are correlated. J Cell Sci 2004; 117: 2791-2804.
59. Verburg J, Hollenbeck PJ: Mitochondrial membrane potential in axons increases with local nerve growth factor or semaphorin signaling. J Neurosci 2008; 28: 8306-8315.
60. Hillefors M, Gioio AE, Mameza MG, Kaplan BB: Axon viability and mitochondrial function are dependent on local protein synthesis in sympathetic neurons. Cell Mol Neurobiol 2007; 27: 701-716.
61. Gioio AE, Eyman M, Zhang H, Lavina ZS, Giuditta A, Kaplan BB: Local synthesis of nuclear-encoded mitochondrial proteins in the presynaptic nerve terminal. J Neurosci Res 2001; 64: 447-453.
62. Amiri M, Hollenbeck PJ: Mitochondrial biogenesis in the axons of vertebrate peripheral neurons. Dev Neurobiol 2008; 68: 1348-1361.
63. Hirai K, Aliev G, Nunomura A, Fujioka H, Russell RL, Atwood CS, Johnson AB, Kress Y, Vinters HV, Tabaton M, Shimohama S, Cash AD, Siedlak SL, Harris PL, Jones PK, Petersen RB, Perry G, Smith MA: Mitochondrial abnormalities in Alzheimer's disease. J Neurosci 2001; 21: 3017-3023.
64. Praprotnik D, Smith MA, Richey PL, Vinters HV, Perry G: Filament heterogeneity within the dystrophic neurites of senile plaques suggests blockage of fast axonal transport in Alzheimer's disease. Acta Neuropathol 1996; 91: 226-235.
65. Terry RD: The pathogenesis of Alzheimer disease: an alternative to the amyloid hypothesis. J Neuropathol Exp Neurol 1996; 55: 1023-1025.
66. Wang X, Su B, Lee HG, Li X, Perry G, Smith MA, Zhu X: Impaired balance of mitochondrial fission and fusion in Alzheimer's disease. J Neurosci 2009; 29: 9090-9103.
67. Priault M, Salin B, Schaeffer J, Vallette FM, di Rago JP, Martinou JC: Impairing the bioenergetic status and the biogenesis of mitochondria triggers mitophagy in yeast. Cell Death Differ 2005; 12: 1613-1621.
68. Tal R, Winter G, Ecker N, Klionsky DJ, Abeliovich H: Aup1p, a yeast mitochondrial protein phosphatase homolog, is required for efficient stationary phase mitophagy and cell survival. J Biol Chem 2007; 282: 5617-5624.
69. Stokin GB, Goldstein LS: Axonal transport and Alzheimer's disease. Annu Rev Biochem 2006; 75: 607-627.
70. Coleman M: Axon degeneration mechanisms: commonality amid diversity. Nat Rev Neurosci 2005; 6: 889-898.
71. Gotz J, Ittner LM, Kins S: Do axonal defects in tau and amyloid precursor protein transgenic animals model axonopathy in Alzheimer's disease? J Neurochem 2006; 98: 993-1006.
72. Gouras GK, Almeida CG, Takahashi RH: Intraneuronal Abeta accumulation and origin of plaques in Alzheimer's disease. Neurobiol Aging 2005; 26: 1235-1244.
73. Kidd GL: Excitation of primary muscle spindle endings by beta-axon stimulation. Nature 1964; 203: 1248-1251.
74. Fiala JC: Mechanisms of amyloid plaque pathogenesis. Acta Neuropathol 2007; 114: 551-571.
75. Fiala JC, Feinberg M, Peters A, Barbas H: Mitochondrial degeneration in dystrophic neurites of senile plaques may lead to extracellular deposition of fine filaments. Brain Struct Funct 2007; 212: 195-207.
76. Morfini G, Szebenyi G, Elluru R, Ratner N, Brady ST: Glycogen synthase kinase 3 phosphorylates kinesin light chains and negatively regulates kinesin-based motility. EMBO J 2002; 21: 281-293.
77. Morfini G, Pigino G, Beffert U, Busciglio J, Brady ST: Fast axonal transport misregulation and Alzheimer's disease. Neuromolecular Med 2002; 2: 89-99.
78. Stamer K, Vogel R, Thies E, Mandelkow E, Mandelkow EM: Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress. J Cell Biol 2002; 156: 1051-1063.
79. Dixit R, Ross JL, Goldman YE, Holzbaur EL: Differential regulation of dynein and kinesin motor proteins by tau. Science 2008; 319: 1086-1089.
80. Morfini G, Pigino G, Mizuno N, Kikkawa M, Brady ST: Tau binding to microtubules does not directly affect microtubule-based vesicle motility. J Neurosci Res 2007; 85: 2620-2630.
81. Kanaan NM, Morfini GA, LaPointe NE, Pigino GF, Patterson KR, Song Y, Andreadis A, Fu Y, Brady ST, Binder LI: Pathogenic forms of tau inhibit kinesin-dependent axonal transport through a mechanism involving activation of axonal phosphotransferases. J Neurosci 2011; 31: 9858-9868.
82. LaPointe NE, Morfini G, Pigino G, Gaisina IN, Kozikowski AP, Binder LI, Brady ST: The amino terminus of tau inhibits kinesin-dependent axonal transport: implications for filament toxicity. J Neurosci Res 2009; 87: 440-451.
83. Seitz A, Kojima H, Oiwa K, Mandelkow EM, Song YH, Mandelkow E: Single-molecule investigation of the interference between kinesin, tau and MAP2c. EMBO J 2002; 21: 4896-4905.
84. Wagner U, Utton M, Gallo JM, Miller CC: Cellular phosphorylation of tau by GSK-3 beta influences tau binding to microtubules and microtubule organisation. J Cell Sci 1996; 109(Pt 6):1537-1543.
85. Kins S, Kurosinski P, Nitsch RM, Gotz J: Activation of the ERK and JNK signaling pathways caused by neuron-specific inhibition of PP2A in transgenic mice. Am J Pathol 2003; 163: 833-843.
86. Mandelkow EM, Thies E, Trinczek B, Biernat J, Mandelkow E: MARK/PAR1 kinase is a regulator of microtubule-dependent transport in axons. J Cell Biol 2004; 167: 99-110.
87. Reiman EM, Caselli RJ, Yun LS, Chen K, Bandy D, Minoshima S, Thibodeau SN, Osborne D: Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E. N Engl J Med 1996; 334: 752-758.
88. Small GW, Ercoli LM, Silverman DH, Huang SC, Komo S, Bookheimer SY, Lavretsky H, Miller K, Siddarth P, Rasgon NL, Mazziotta JC, Saxena S, Wu HM, Mega MS, Cummings JL, Saunders AM, Pericak-Vance MA, Roses AD, Barrio JR, Phelps ME: Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease. Proc Natl Acad Sci USA 2000; 97: 6037-6042.
89. Reiman EM, Chen K, Alexander GE, Caselli RJ, Bandy D, Osborne D, Saunders AM, Hardy J: Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia. Proc Natl Acad Sci USA 2004; 101: 284-289.
90. Stieler JT, Bullmann T, Kohl F, Toien O, Bruckner MK, Hartig W, Barnes BM, Arendt T: The physiological link between metabolic rate depression and tau phosphorylation in mammalian hibernation. PLoS ONE 2011; 6:e14530.
91. Escobar-Khondiker M, Hollerhage M, Muriel MP, Champy P, Bach A, Depienne C, Respondek G, Yamada ES, Lannuzel A, Yagi T, Hirsch EC, Oertel WH, Jacob R, Michel PP, Ruberg M, Hoglinger GU: Annonacin, a natural mitochondrial complex I inhibitor, causes tau pathology in cultured neurons. J Neurosci 2007; 27: 7827-7837.
92. Chee FC, Mudher A, Cuttle MF, Newman TA, MacKay D, Lovestone S, Shepherd D: Over-expression of tau results in defective synaptic transmission in Drosophila neuromuscular junctions. Neurobiol Dis 2005; 20: 918-928.
93. Dickson TC, King CE, McCormack GH, Vickers JC: Neurochemical diversity of dystrophic neurites in the early and late stages of Alzheimer's disease. Exp Neurol 1999; 156: 100-110.
94. Haass C, Selkoe DJ: Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide. Nat Rev Mol Cell Biol 2007; 8: 101-112.
95. Smith KD, Kallhoff V, Zheng H, Pautler RG: In vivo axonal transport rates decrease in a mouse model of Alzheimer's disease. Neuroimage 2007; 35: 1401-1408.
96. Zempel H, Thies E, Mandelkow E, Mandelkow EM: Abeta oligomers cause localized Ca(2+) elevation, missorting of endogenous Tau into dendrites, Tau phosphorylation, and destruction of microtubules and spines. J Neurosci 2010; 30: 11938-11950.
97. Decker H, Lo KY, Unger SM, Ferreira ST, Silverman MA: Amyloid-beta peptide oligomers disrupt axonal transport through an NMDA receptor-dependent mechanism that is mediated by glycogen synthase kinase 3beta in primary cultured hippocampal neurons. J Neurosci 2010; 30: 9166-9171.
98. Vossel KA, Zhang K, Brodbeck J, Daub AC, Sharma P, Finkbeiner S, Cui B, Mucke L: Tau reduction prevents Abeta-induced defects in axonal transport. Science 2010; 330: 198.
99. Rui Y, Tiwari P, Xie Z, Zheng JQ: Acute impairment of mitochondrial trafficking by beta-amyloid peptides in hippocampal neurons. J Neurosci 2006; 26: 10480-10487.
100. Pigino G, Morfini G, Atagi Y, Deshpande A, Yu C, Jungbauer L, LaDu M, Busciglio J, Brady S: Disruption of fast axonal transport is a pathogenic mechanism for intraneuronal amyloid beta. Proc Natl Acad Sci USA 2009; 106: 5907-5912.
101. Zhao XL, Wang WA, Tan JX, Huang JK, Zhang X, Zhang BZ, Wang YH, Yang Cheng HY, Zhu HL, Sun XJ, Huang FD: Expression of beta-amyloid induced age-dependent presynaptic and axonal changes in Drosophila. J Neurosci 2010; 30: 1512-1522.
102. Wirths O, Weis J, Szczygielski J, Multhaup G, Bayer TA: Axonopathy in an APP/PS1 transgenic mouse model of Alzheimer's disease. Acta neuropathologica 2006; 111: 312-319.
103. Morin PJ, Abraham CR, Amaratunga A, Johnson RJ, Huber G, Sandell JH, Fine RE: Amyloid precursor protein is synthesized by retinal ganglion cells, rapidly transported to the optic nerve plasma membrane and nerve terminals, and metabolized. J Neurochem 1993; 61: 464-473.
104. Amaratunga A, Leeman SE, Kosik KS, Fine RE: Inhibition of kinesin synthesis in vivo inhibits the rapid transport of representative proteins for three transport vesicle classes into the axon. J Neurochem 1995; 64: 2374-2376.
105. Szodorai A, Kuan YH, Hunzelmann S, Engel U, Sakane A, Sasaki T, Takai Y, Kirsch J, Muller U, Beyreuther K, Brady S, Morfini G, Kins S: APP anterograde transport requires Rab3A GTPase activity for assembly of the transport vesicle. J Neurosci 2009; 29: 14534-14544.
106. Kaether C, Skehel P, Dotti CG: Axonal membrane proteins are transported in distinct carriers: a two-color video microscopy study in cultured hippocampal neurons. Mol Biol Cell 2000; 11: 1213-1224.
107. Yamazaki H, Nakata T, Okada Y, Hirokawa N: KIF3A/B: a heterodimeric kinesin superfamily protein that works as a microtubule plus end-directed motor for membrane organelle transport. J Cell Biol 1995; 130: 1387-1399.
108. Ferreira A, Caceres A, Kosik KS: Intraneuronal compartments of the amyloid precursor protein. J Neurosci 1993; 13: 3112-3123.
109. Koo EH, Sisodia SS, Archer DR, Martin LJ, Weidemann A, Beyreuther K, Fischer P, Masters CL, Price DL: Precursor of amyloid protein in Alzheimer disease undergoes fast anterograde axonal transport. Proc Natl Acad Sci USA 1990; 87: 1561-1565.
110. Yamazaki T, Selkoe DJ, Koo EH: Trafficking of cell surface beta-amyloid precursor protein: retrograde and transcytotic transport in cultured neurons. J Cell Biol 1995; 129: 431-442.
111. Kamal A, Stokin GB, Yang Z, Xia CH, Goldstein LS: Axonal transport of amyloid precursor protein is mediated by direct binding to the kinesin light chain subunit of kinesin-I. Neuron 2000; 28: 449-459.
112. Kamal A, Goldstein LS: Principles of cargo attachment to cytoplasmic motor proteins. Curr Opin Cell Biol 2002; 14: 63-68.
113. Satpute-Krishnan P, DeGiorgis JA, Conley MP, Jang M, Bearer EL: A peptide zipcode sufficient for anterograde transport within amyloid precursor protein. Proc Natl Acad Sci USA 2006; 103: 16532-16537.
114. Lazarov O, Morfini GA, Lee EB, Farah MH, Szodorai A, DeBoer SR, Koliatsos VE, Kins S, Lee VM, Wong PC, Price DL, Brady ST, Sisodia SS: Axonal transport, amyloid precursor protein, kinesin-1, and the processing apparatus: revisited. J Neurosci 2005; 25: 2386-2395.
115. Matsuda S, Matsuda Y, D'Adamio L: Amyloid beta protein precursor (AbetaPP), but not AbetaPP-like protein 2, is bridged to the kinesin light chain by the scaffold protein JNK-interacting protein 1. J Biol Chem 2003; 278: 38601-38606.
116. Inomata H, Nakamura Y, Hayakawa A, Takata H, Suzuki T, Miyazawa K, Kitamura N: A scaffold protein JIP-1b enhances amyloid precursor protein phosphorylation by JNK and its association with kinesin light chain 1. J Biol Chem 2003; 278: 22946-22955.
117. Tienari PJ, De Strooper B, Ikonen E, Simons M, Weidemann A, Czech C, Hartmann T, Ida N, Multhaup G, Masters CL, Van Leuven F, Beyreuther K, Dotti CG: The betaamyloid domain is essential for axonal sorting of amyloid precursor protein. EMBO J 1996; 15: 5218-5229.
118. Rusu P, Jansen A, Soba P, Kirsch J, Lower A, Merdes G, Kuan YH, Jung A, Beyreuther K, Kjaerulff O, Kins S: Axonal accumulation of synaptic markers in APP transgenic Drosophila depends on the NPTY motif and is paralleled by defects in synaptic plasticity. Eur J Neurosci 2007; 25: 1079-1086.
119. Back S, Haas P, Tschape JA, Gruebl T, Kirsch J, Muller U, Beyreuther K, Kins S: Beta-amyloid precursor protein can be transported independent of any sorting signal to the axonal and dendritic compartment. J Neurosci Res 2007; 85: 2580-2590.
120. Rahman A, Friedman DS, Goldstein LS: Two kinesin light chain genes in mice. Identification and characterization of the encoded proteins. J Biol Chem 1998; 273: 15395-15403.
121. Bowman AB, Kamal A, Ritchings BW, Philp AV, McGrail M, Gindhart JG, Goldstein LS: Kinesin-dependent axonal transport is mediated by the sunday driver (SYD) protein. Cell 2000; 103: 583-594.
122. Stokin GB, Lillo C, Falzone TL, Brusch RG, Rockenstein E, Mount SL, Raman R, Davies P, Masliah E, Williams DS, Goldstein LS: Axonopathy and transport deficits early in the pathogenesis of Alzheimer's disease. Science 2005; 307: 1282-1288.
123. Gotz J, Chen F, van Dorpe J, Nitsch RM: Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Abeta 42 fibrils. Science 2001; 293: 1491-1495.
124. Ittner LM, Ke YD, Delerue F, Bi M, Gladbach A, van Eersel J, Wolfing H, Chieng BC, Christie MJ, Napier IA, Eckert A, Staufenbiel M, Hardeman E, Gotz J: Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer's disease mouse models. Cell 2010; 142: 387-397.
125. Wang X, Su B, Siedlak SL, Moreira PI, Fujioka H, Wang Y, Casadesus G, Zhu X: Amyloid- beta overproduction causes abnormal mitochondrial dynamics via differential modulation of mitochondrial fission/ fusion proteins. Proc Natl Acad Sci USA 2008; 105: 19318-19323.
126. Wang X, Su B, Fujioka H, Zhu X: Dynaminlike protein 1 reduction underlies mitochondrial morphology and distribution abnormalities in fibroblasts from sporadic Alzheimer's disease patients. Am J Pathol 2008; 173: 470-482.
127. Cho DH, Nakamura T, Fang J, Cieplak P, Godzik A, Gu Z, Lipton SA: S-nitrosylation of Drp1 mediates beta-amyloid-related mitochondrial fission and neuronal injury. Science 2009; 324: 102-105.
128. Sarti P, Arese M, Giuffre A: The molecular mechanisms by which nitric oxide controls mitochondrial complex IV. Ital J Biochem 2003; 52: 37-42.
129. Radi R, Cassina A, Hodara R, Quijano C, Castro L: Peroxynitrite reactions and formation in mitochondria. Free Radic Biol Med 2002; 33: 1451-1464.
130. Guix FX, Wahle T, Vennekens K, Snellinx A, Chavez-Gutierrez L, Ill-Raga G, Ramos- Fernandez E, Guardia-Laguarta C, Lleo A, Arimon M, Berezovska O, Munoz FJ, Dotti CG, De Strooper B: Modification of gamma- secretase by nitrosative stress links neuronal ageing to sporadic Alzheimer's disease. EMBO Mol Med 2012; 4: 660-673.
131. Devi L, Prabhu BM, Galati DF, Avadhani NG, Anandatheerthavarada HK: Accumulation of amyloid precursor protein in the mitochondrial import channels of human Alzheimer's disease brain is associated with mitochondrial dysfunction. J Neurosci 2006; 26: 9057-9068.
132. Anandatheerthavarada HK, Biswas G, Robin MA, Avadhani NG: Mitochondrial targeting and a novel transmembrane arrest of Alzheimer's amyloid precursor protein impairs mitochondrial function in neuronal cells. J Cell Biol 2003; 161: 41-54.
133. Yoon EJ, Park HJ, Kim GY, Cho HM, Choi JH, Park HY, Jang JY, Rhim HS, Kang SM: Intracellular amyloid beta interacts with SOD1 and impairs the enzymatic activity of SOD1: implications for the pathogenesis of amyotrophic lateral sclerosis. Exp Mol Med 2009; 41: 611-617.
134. Milton NG: Amyloid-beta binds catalase with high affinity and inhibits hydrogen peroxide breakdown. Biochem J 1999; 344(Pt 2):293-296.
135. Yan SD, Fu J, Soto C, Chen X, Zhu H, Al- Mohanna F, Collison K, Zhu A, Stern E, Saido T, Tohyama M, Ogawa S, Roher A, Stern D: An intracellular protein that binds amyloid-beta peptide and mediates neurotoxicity in Alzheimer's disease. Nature 1997; 389: 689-695.
136. He XY, Merz G, Mehta P, Schulz H, Yang SY: Human brain short chain L-3-hydroxyacyl coenzyme A dehydrogenase is a single-domain multifunctional enzyme. Characterization of a novel 17beta-hydroxysteroid dehydrogenase. J Biol Chem 1999; 274: 15014-15019.
137. Du H, Guo L, Fang F, Chen D, Sosunov AA, McKhann GM, Yan Y, Wang C, Zhang H, Molkentin JD, Gunn-Moore FJ, Vonsattel JP, Arancio O, Chen JX, Yan SD: Cyclophilin D deficiency attenuates mitochondrial and neuronal perturbation and ameliorates learning and memory in Alzheimer's disease. Nat Med 2008; 14: 1097-1105.
138. Kann O, Kovacs R: Mitochondria and neuronal activity. Am J Physiol Cell Physiol 2007; 292:C641-657.
139. Verstreken P, Ly CV, Venken KJ, Koh TW, Zhou Y, Bellen HJ: Synaptic mitochondria are critical for mobilization of reserve pool vesicles at Drosophila neuromuscular junctions. Neuron 2005; 47: 365-378.
140. Lee CW, Peng HB: The function of mitochondria in presynaptic development at the neuromuscular junction. Mol Biol Cell 2008; 19: 150-158.
141. Hollenbeck PJ: Mitochondria and neurotransmission: evacuating the synapse. Neuron 2005; 47: 331-333.
142. Tang Y, Zucker RS: Mitochondrial involvement in post-tetanic potentiation of synaptic transmission. Neuron 1997; 18: 483-491.
143. Yang F, He XP, Russell J, Lu B: Ca 2+ influxindependent synaptic potentiation mediated by mitochondrial Na(+)-Ca 2+ exchanger and protein kinase C. J Cell Biol 2003; 163: 511-523.
144. Murphy MP: How mitochondria produce reactive oxygen species. Biochem J 2009; 417: 1-13.
145. Starkov AA, Fiskum G, Chinopoulos C, Lorenzo BJ, Browne SE, Patel MS, Beal MF: Mitochondrial alpha-ketoglutarate dehydrogenase complex generates reactive oxygen species. J Neurosci 2004; 24: 7779-7788.
146. Andreyev AY, Kushnareva YE, Starkov AA: Mitochondrial metabolism of reactive oxygen species. Biochemistry (Mosc) 2005; 70: 200-214.
147. Lee JM, Calkins MJ, Chan K, Kan YW, Johnson JA: Identification of the NF-E2- related factor-2-dependent genes conferring protection against oxidative stress in primary cortical astrocytes using oligonucleotide microarray analysis. J Biol Chem 2003; 278: 12029-12038.
148. Devries MC, Hamadeh MJ, Glover AW, Raha S, Samjoo IA, Tarnopolsky MA: Endurance training without weight loss lowers systemic, but not muscle, oxidative stress with no effect on inflammation in lean and obese women. Free Radic Biol Med 2008; 45: 503-511.
149. Brunelle JK, Bell EL, Quesada NM, Vercauteren K, Tiranti V, Zeviani M, Scarpulla RC, Chandel NS: Oxygen sensing requires mitochondrial ROS but not oxidative phosphorylation. Cell Metabol 2005; 1: 409-414.
150. Guzy RD, Hoyos B, Robin E, Chen H, Liu L, Mansfield KD, Simon MC, Hammerling U, Schumacker PT: Mitochondrial complex III is required for hypoxia-induced ROS production and cellular oxygen sensing. Cell Metabol 2005; 1: 401-408.
151. Bell EL, Klimova TA, Eisenbart J, Moraes CT, Murphy MP, Budinger GR, Chandel NS: The Qo site of the mitochondrial complex III is required for the transduction of hypoxic signaling via reactive oxygen species production. J Cell Biol 2007; 177: 1029-1036.
152. Kamata H, Manabe T, Oka S, Kamata K, Hirata H: Hydrogen peroxide activates IkappaB kinases through phosphorylation of serine residues in the activation loops. FEBS Lett 2002; 519: 231-237.
153. Tan M, Li S, Swaroop M, Guan K, Oberley LW, Sun Y: Transcriptional activation of the human glutathione peroxidase promoter by p53. J Biol Chem 1999; 274: 12061-12066.
154. Hussain SP, Amstad P, He P, Robles A, Lupold S, Kaneko I, Ichimiya M, Sengupta S, Mechanic L, Okamura S, Hofseth LJ, Moake M, Nagashima M, Forrester KS, Harris CC: p53-induced up-regulation of MnSOD and GPx but not catalase increases oxidative stress and apoptosis. Cancer Res 2004; 64: 2350-2356.
155. Moreira PI, Zhu X, Wang X, Lee HG, Nunomura A, Petersen RB, Perry G, Smith MA: Mitochondria: a therapeutic target in neurodegeneration. Biochim Biophys Acta 2010; 1802: 212-220.
156. Halliwell B, Dizdaroglu M: The measurement of oxidative damage to DNA by HPLC and GC/MS techniques. Free Radic Res Commun 1992; 16: 75-87.
157. Ankarcrona M, Dypbukt JM, Bonfoco E, Zhivotovsky B, Orrenius S, Lipton SA, Nicotera P: Glutamate-induced neuronal death: a succession of necrosis or apoptosis depending on mitochondrial function. Neuron 1995; 15: 961-973.
158. Dugan LL, Sensi SL, Canzoniero LM, Handran SD, Rothman SM, Lin TS, Goldberg MP, Choi DW: Mitochondrial production of reactive oxygen species in cortical neurons following exposure to N-methyl- D -aspartate. J Neurosci 1995; 15: 6377-6388.
159. Moreira PI, Santos MS, Moreno A, Rego AC, Oliveira C: Effect of amyloid beta-peptide on permeability transition pore: a comparative study. J Neurosci Res 2002; 69: 257-267.
160. Kish SJ, Bergeron C, Rajput A, Dozic S, Mastrogiacomo F, Chang LJ, Wilson JM, DiStefano LM, Nobrega JN: Brain cytochrome oxidase in Alzheimer's disease. J Neurochem 1992; 59: 776-779.
161. Sorbi S, Bird ED, Blass JP: Decreased pyruvate dehydrogenase complex activity in Huntington and Alzheimer brain. Ann Neurol 1983; 13: 72-78.
162. Mastrogiacoma F, Lindsay JG, Bettendorff L, Rice J, Kish SJ: Brain protein and alphaketoglutarate dehydrogenase complex activity in Alzheimer's disease. Ann Neurol 1996; 39: 592-598.
163. Ojaimi J, Masters CL, McLean C, Opeskin K, McKelvie P, Byrne E: Irregular distribution of cytochrome c oxidase protein subunits in aging and Alzheimer's disease. Ann Neurol 1999; 46: 656-660.
164. Hirai K, Aliev G, Nunomura A, Fujioka H, Russell RL, Atwood CS, Johnson AB, Kress Y, Vinters HV, Tabaton M, Shimohama S, Cash AD, Siedlak SL, Harris PL, Jones PK, Petersen RB, Perry G, Smith MA: Mitochondrial abnormalities in Alzheimer's disease. J Neurosci 2001; 21: 3017-3023.
165. Castellani R, Hirai K, Aliev G, Drew KL, Nunomura A, Takeda A, Cash AD, Obrenovich ME, Perry G, Smith MA: Role of mitochondrial dysfunction in Alzheimer's disease. J Neurosci Res 2002; 70: 357-360.
166. Wang R, Meschia JF, Cotter RJ, Sisodia SS: Secretion of the beta/A4 amyloid precursor protein. Identification of a cleavage site in cultured mammalian cells. J Biol Chem 1991; 266: 16960-16964.
167. Saura J, Luque JM, Cesura AM, Da Prada M, Chan-Palay V, Huber G, Loffler J, Richards JG: Increased monoamine oxidase B activity in plaque-associated astrocytes of Alzheimer brains revealed by quantitative enzyme radioautography. Neuroscience 1994; 62: 15-30.
168. Kennedy BP, Ziegler MG, Alford M, Hansen LA, Thal LJ, Masliah E: Early and persistent alterations in prefrontal cortex MAO A and B in Alzheimer's disease. J Neural Transm 2003; 110: 789-801.
169. Hauptmann S, Scherping I, Drose S, Brandt U, Schulz KL, Jendrach M, Leuner K, Eckert A, Muller WE: Mitochondrial dysfunction: an early event in Alzheimer pathology accumulates with age in AD transgenic mice. Neurobiol Aging 2009; 30: 1574-1586.
170. Fu YJ, Xiong S, Lovell MA, Lynn BC: Quantitative proteomic analysis of mitochondria in aging PS-1 transgenic mice. Cell Mol Neurobiol 2009; 29: 649-664.
171. Aliev G, Seyidova D, Neal ML, Shi J, Lamb BT, Siedlak SL, Vinters HV, Head E, Perry G, Lamanna JC, Friedland RP, Cotman CW: Atherosclerotic lesions and mitochondria DNA deletions in brain microvessels as a central target for the development of human AD and AD-like pathology in aged transgenic mice. Ann NY Acad Sci 2002; 977: 45-64.
172. Schuessel K, Schafer S, Bayer TA, Czech C, Pradier L, Muller-Spahn F, Muller WE, Eckert A: Impaired Cu/Zn-SOD activity contributes to increased oxidative damage in APP transgenic mice. Neurobiol Dis 2005; 18: 89-99.
173. Gillardon F, Rist W, Kussmaul L, Vogel J, Berg M, Danzer K, Kraut N, Hengerer B: Proteomic and functional alterations in brain mitochondria from Tg2576 mice occur before amyloid plaque deposition. Proteomics 2007; 7: 605-616.
174. Aliyev A, Chen SG, Seyidova D, Smith MA, Perry G, de la Torre J, Aliev G: Mitochondria DNA deletions in atherosclerotic hypoperfused brain microvessels as a primary target for the development of Alzheimer's disease. J Neurol Sci 2005; 229-230: 285-292.
175. Rhein V, Song X, Wiesner A, Ittner LM, Baysang G, Meier F, Ozmen L, Bluethmann H, Drose S, Brandt U, Savaskan E, Czech C, Gotz J, Eckert A: Amyloid-beta and tau synergistically impair the oxidative phosphorylation system in triple transgenic Alzheimer's disease mice. Proc Natl Acad Sci USA 2009; 106: 20057-20062.
176. Pereira C, Santos MS, Oliveira C: Mitochondrial function impairment induced by amyloid beta-peptide on PC12 cells. Neuroreport 1998; 9: 1749-1755.
177. Cardoso SM, Santos S, Swerdlow RH, Oliveira CR: Functional mitochondria are required for amyloid beta-mediated neurotoxicity. FASEB J 2001; 15: 1439-1441.